
Susana M. Campos, MD, gynecologic oncologist, Dana-Farber Cancer Institute, assistant professor of medicine, Harvard Medical School, discusses next steps with PARP inhibitors in ovarian cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: October 15th 2018 | Updated: